Acute renal failure following bone marrow transplantation

References

• Rieselbach RE, Gamick MD. Renal diseases induced by antineoplastic agents. Diseases of the Kidney, RW Schrier, CW Gottschalk. Little, Brown, Boston 1988; 1292–1293
   Google Scholar
• Conger JD. Acute uric acid nephropathy. Med Clin North Am 1990; 74: 859–871
   PubMed Web of Science ®Google Scholar
• Broun ER, Nichols CR, Tricot G, Loehrer PJ, Williams SD. Autologous bone marrow support in the treatment of refractory germ cell tumors. Bone marrow transplant 1991; 7: 53–56
   PubMed Web of Science ®Google Scholar
• Cannell PK, Herrmann RP. Urate metabolism during bone marrow transplantation. Bone Marrow Transplant 1992; 10: 337–339
   PubMed Web of Science ®Google Scholar
• Rowle SC. Hematopoietic stem cell cryopreservation: a review of current associated with cryopreserved and thawed peripheral blood stem cell autografts in children with active techniques. J Hematotherapy 1992; 1: 233–250
   PubMedGoogle Scholar
• Davis JM, Rowley SC, Braine HG, Plantadosi S, Santos GW. Clinical toxicity of cryopreserved bone marrow graft infusion. Blood 1990; 75: 781–786
   PubMed Web of Science ®Google Scholar
• Kamoto Y, Takauc Y, Saitos, Shimitzu T, Abe T, Sato J, Hirao A, Watanabe T, Kawano Y, Kuroda Y. Toxicities associated with cryopreserved and thawed peripheral blood stem cell autografts in children with active cancer. Transfusion 1993; 33: 578–581
   PubMed Web of Science ®Google Scholar
• Styler MJ, Topolsky DL, Crilley PA, Covalsesky V, Bryan R, Bulova S, Brodsky I. Transient high grade heart block following autologous bone marrow infusion. Bone Marrow Transplant 1992; 10: 435–438
   PubMed Web of Science ®Google Scholar
• Kessinger A, Schmit-Pokomy D, Smith D, Armitage J. Cryopreservation and infusion of autologous peripheral blood stem cells. Bone Marrow Transplant 1990; 5: 25–27, suppl 1
   PubMed Web of Science ®Google Scholar
• Smith DM, Weisenberger DD, Bierman P, Kessinger A, Vaughan WP, Armitage JO. Acute renal failure associated with autologous bone marrow transplantation. Bone Marrow Transplant 1987; 2: 195–210
   PubMed Web of Science ®Google Scholar
• Yellowless P, Greenfield C, McIntyre N. Dimethylsulphoxide induced toxicity. Lancet 1980; 2: 1004–1006
   PubMed Web of Science ®Google Scholar
• Zager RA. Heme protein-ischemic interactions at the vascular, intraluminal, and renal tubular cell levels: implications for therapy of myoglobin-induced renal injury. Renal Failure 1992; 14: 341–344
   PubMed Web of Science ®Google Scholar
• Jaenike JR. Micropuncture study of methemoglohin-induced acute renal failure in the rat. J Lab Clin Med, 73: 459–468; 19
   PubMed Web of Science ®Google Scholar
• Zager RA, Gamelin LM. Pathogenetic mechanisms in experimental hemoglobinuric acute renal failure. Am J Physiol 1989; 25: F446–F455
   Google Scholar
• Zager RA, O'Quigley J, Zager BK, Alpers CE, Shulman HM, Gamelin LM, Stewart P, Thomas ED. Acute Renal failure following bone marrow transplantatiion: a retrospective study of 272 patients. Am J Kidney Dis 1989; 13: 210–216
   PubMed Web of Science ®Google Scholar
• Gruss E, Bernis C, Thomas JF, Garcia-Canton C, Figuera A, Berberana M, Paraiso V, Hemandez-Jaros J, Lopez, Ranada F, Traver JA. Acute renal failure and bone marrow transplantation. Renal Failure 1993; 15: 671–672
   Google Scholar
• Baldus WP, Fleitchter RN, Summerskill WHJ. The Kidney in cirrhosis. Clinical and biochemical features of azotemia in hepatic failure. Ann Int Med 1964; 60: 353–365
   PubMed Web of Science ®Google Scholar
• Shuhart MC, McDonald GB. Gastrointestinal and hepatic complications. Bone Marrow Transplantation, SJ Forman, KG Blume, ED Thomas. Blackwell;, Cambridge, MA 1994; 454–481, (chapt 33)
   Google Scholar
• McDonald GB, Sharma P, Mathews DE, Shulman HM, Thomas ED. Veno-occlusive disease of the liver after bone marrow transplantation: diagnosis, incidence, and predisposing factors. Hepatology 1984; 4: 116–122
   PubMed Web of Science ®Google Scholar
• Jones RJ, Lee KS, Besc homer WE, Vogel VG, Grochow LB, Braine HG, Vogelsang GB, Sensenbramer LL, Santos GW, Saral R. Veno-occlusive disease of the liver following bone marrow transplantation. Transplantation 1981; 44: 778–783
   Google Scholar
• Ganem G, Saint-Marc Girardin MF, Kuentz M, Cordonnier Marinello G, Teboul C, Bracconnier F, Vemant JP, Dhumeaux D, Le bourgeois JP. Veno-occlusive disease of the liver after allogenic bone marrow transplantation in man. Int J Radiat Oncol Biol Phys 1988; 14: 879–884
   PubMed Web of Science ®Google Scholar
• Nevill TJ, Barrett MJ, Klingnann HG, Reece DE, Shepherd JD, Phillips GL. Regimen-related toxicity of a busulfan-cyclophosphomide conditioning regimen in 70 patients undergoing allogeneic bone marrow transplantation. J Clin Oncol 1991; 9: 1224–1232
   PubMed Web of Science ®Google Scholar
• McDonald GB, Hinds MS, Fisher LD, Schoch HG, Wolford JL, Banaji M, Hardin BJ, Shuhnan HM, Cliff RA. Veno-occlusive disease of the liver and multiorgan failure after bone marrow transplantation: a cohort study of 355 patients. Ann Intern Med 1993; 118: 255–267
   PubMed Web of Science ®Google Scholar
• Levy M. Nephrology Forum: Hepatorehal syndrome. Kidney Int 1993; 43: 737–753
   PubMedGoogle Scholar
• Sawayi BP, Weinpredrt H, Campbell WR, Lorenz JN, Webb RL, Briggs JP, Schnermann J. Direct vasoconstriction as a possible cause of amphotericin B induced nephrotoxicity in rats. J Clin Invest 1991; 87: 2097–2107
   PubMed Web of Science ®Google Scholar
• Butler WT, Banett JE, Alling DW, Westlake PT, Utz JP, Hill GJ. Nephrotoxicity of amphotericin B: Early and late effects in 81 patients. Ann Intern Med 1964; 61: 175–187
   PubMed Web of Science ®Google Scholar
• Moore RD, Smith CR, Lictman PS. Increased risk of renal dysfunction due to interaction of liver disease and aminoglycosides. Am J Med 1986; 80: 1093–1097
   PubMed Web of Science ®Google Scholar
• Gabrera J, Arroyo U, Ballesto AM, Rimola AJ, Elena M, Gual J, Rodes J. Aminoglycoside nephrotoxicity in cirrhosis. Gastroenterology 1982; 82: 97–105
   PubMedGoogle Scholar
• Churchill DN, Hong K, Gault MH. Radiation nephritis following combined abdominal radion and chemotherapy (bleomycin-vinblastine). Cancer 1976; 37: 1186
   PubMedGoogle Scholar
• Bevilacqua MP, Pober JS, Majeau GR, Fiers W, Conran RS, Gimbrone MA, Jr. Recombinant tumor necrosis factor induces procoagulant activity in cultured human vascular endothelium: characterization and comparison with the actions of interleukin 1. Proc Natl Acad Sci 1986; 83: 4533–4537
   PubMed Web of Science ®Google Scholar
• Geriach H, Esposito C, Stern DM. Modulation of endothelial hemostatic properties: An active role in the host response. Ann Rev Med 1990; 41: 15–24
   PubMed Web of Science ®Google Scholar
• Jaattela M. Biologic activities and mechanisms of action of tumor necrosis factor-alpha/cadhexin. Lab Invest 1991; 64: 724–742
   PubMed Web of Science ®Google Scholar
• Beannan SI, Shuhart MC, Hinds MS, McDonald GB. Recombinant human tissue plasminogen activator for the treatment of established severe verso-occlusive disease of the liver after bone marrow transplantation. Blood 1992; 80: 2458–2462
   PubMed Web of Science ®Google Scholar
• Gale RP, Sparkes RS, Golde DW. Bone marrow margin origin of hepatic macrophages (kuppfer cells) in humans. Science 1978; 201: 937–938
   PubMed Web of Science ®Google Scholar
• Pinsky MR, Matusdhak GM. A unifying hypothesis of multiple systems organ failure: failure of host defense homeostasis. J Crit Care 1990; 5: 108–114
   Web of Science ®Google Scholar
• Zager RA. Nephrology forum: acute renal failure in the setting of bone marrow transplantation. Kidney Int 1994; 46: 1443–1458
   PubMed Web of Science ®Google Scholar
• McDonald GB, Hinds MS, Fisher LD, Schoch HG. Veno-occlusive disease of the liver and multiorgan failure after marrow transplantation: a cohort study of 355 patients. Ann Intern Med 1993; 118: 255–267
   PubMed Web of Science ®Google Scholar
• Tarbef NS, Guinan EC, Neimeyer C, Mauch P, Sallan SE, Weinstein HJ. Late onset of renal dysfunction in survivors of bone marrow transplantation. Int J Radiat Oncol Biol Phys 1988; 15: 99–104
   PubMed Web of Science ®Google Scholar
• Bergstein J, Andreoli SP, Provisor AJ, Yurn M. Radiation nephritis following total body irradiation and cyclophosphamide in preparation of bone marrow transplantation. Transplantation 1984; 41: 63
   Web of Science ®Google Scholar
• Lawton CA, Barber-Denis SW, Murray KS, Ash RC, Moulder JE. Influence of renal shielding on the incidence of late renal dysfunction associated with T- lymphocyte depleted bone marrow transplantation in adult patients. Int J Radiat Oncol Biol Phys 1992; 23: 681–686
   PubMed Web of Science ®Google Scholar
• Silva VA, Frei-Lahr D, Brown RA, Herzig GP. Plasma exchange and vincristine in the treatment of hemolytic uremic syndrome/thrombotic thrombocytopenic purpura associated with bone marrow transplantation. J Clin Apheresis 1991; 6: 16–20
   PubMedGoogle Scholar
• Yee GC, Self SG, McGuire TR, Carlin J, Sanders JE, Deeg HJ. Serum cyclosporin concentrations and risk of acute graft-versus-host disease after allogeneic marrow transplantation. N Engl J Med 1988; 319: 65–70
   PubMed Web of Science ®Google Scholar
• Sullivan KM. Graft-versus-host disease. Bone Marrow Transplantation, SJ Forman, KG Blume, ED Thomas. Blackwell, Oxford 1994; 339–362
   Google Scholar
• Deeg HJ, Store R, Thomas ED, Fluornoy N, Kennedy MS, Banaji M, Applebaum FR, Bensinger WI, Buckner CD, Cliff RA, Dorsey K, Fefer A, McGuffin R, Sanders JE, Singer J, Stewart P, Sullivan KM, Witherspoon RP. Cyclosporin as prophylaxis for graft-versus-host disease: a randomized study in patients undergoing marrow transplantation for acute nonlymphoblastic leukemia. Blood 1985; 65: 1325–1334
   PubMed Web of Science ®Google Scholar
• Kennedy MS, Deeg HJ, Siegel M, Crowley JJ, Storb R, Thomas ED. Acute renal toxicity with combined use of amphotericin B and cyclosporin after marrow transplantation. Transplantation 1983; 35: 211–215
   PubMed Web of Science ®Google Scholar
• Storb R, Deeg HJ, Farewll V, Doney K. Marrow transplantation for severe aplastic anemia: methotrexate alone compared with a combination of meths rexate and cyclosporine for prevention of acute graft-versus-host disease. Blood 1986; 68: 119–125
   PubMed Web of Science ®Google Scholar
• Rosey SR, Russler S, Gottleib M, Ash RC. Low dose amphotericin B prophylaxis against invasive aspergillus infections in allogeneic marrow transplantation. Am J Med 1991; 91: 484–492
   PubMed Web of Science ®Google Scholar
• Goodman JL, Wiston DJ, Greenfield RA, Chandrashekar PH, Fox B, Kaizer H, Shadduck RK, Shea TC, Stiff P, Friedman DJ. A controlled trial of fluconazole to prevent fungal infections in patients undergoing bone marrow transplantation. New Engl J Med 1992; 326: 845–851
   PubMed Web of Science ®Google Scholar
• Cohen EP, Lawton CL, Moulder JE. BMT nephropathy: Radiation nephritis revisited. Nephron 1995; 70: 217–222
   PubMed Web of Science ®Google Scholar